Have a personal or library account? Click to login
Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor Cover

Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor

Radiology and Oncology
Volume 57 (2023): Issue 3 (September 2023)
By: Jiyang Tang,  Dejun Shu,  Zhimin Fang and  Gaolan Yang  
Open Access
|Sep 2023

Authors

Jiyang Tang

jytang6040@163.com

Department of Thoracic Surgery, The Third Affiliated Hospital of ZunYi Medical University (The First People's Hospital of ZunYi), Zunyi, China

Dejun Shu

Department of Thoracic Surgery, The Third Affiliated Hospital of ZunYi Medical University (The First People's Hospital of ZunYi), Zunyi, China

Zhimin Fang

Department of Thoracic Surgery, The Third Affiliated Hospital of ZunYi Medical University (The First People's Hospital of ZunYi), Zunyi, China

Gaolan Yang

Department of Thoracic Surgery, The Third Affiliated Hospital of ZunYi Medical University (The First People's Hospital of ZunYi), Zunyi, China
DOI: https://doi.org/10.2478/raon-2023-0033 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 325 - 336
Submitted on: Dec 21, 2022
|
Accepted on: Jun 21, 2023
|
Published on: Sep 4, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
non-small cell lung cancer,
PROM2,
cisplatin,
drug resistance,
CTCF
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2023 Jiyang Tang, Dejun Shu, Zhimin Fang, Gaolan Yang, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 57 (2023): Issue 3 (September 2023)Next article